clinicaltrialsarena56m
Microbion reports topline data from Phase II study of DFI therapy
Microbion has reported positive topline results from its Phase II study of pravibismane, a topical treatment for DFI.
clinicaltrialsarena6h
Lilly reports trial results of tirzepatide for treating obesity and pre-diabetes
At the 15mg dose, participants showed a sustained average weight loss of 22.9% during the three-year treatment. Credit: SB ...
clinicaltrialsarena6h
Putting the DACH region on the map for clinical trials
The DACH region encompasses Germany, Austria, and Switzerland. Credit: Tom Korcak via Shutterstock. Amid tightening EU ...
clinicaltrialsarena23h
Syndax’s stock sinks by 25% despite AML trial meeting primary endpoint
Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...
clinicaltrialsarena23h
Kezar struck again with second FDA hold
They say lightning rarely strikes twice but Kezar Life Sciences has suffered its second clinical blow in as many months.
clinicaltrialsarena23h
Poor posterior occlusion identified as a new risk factor for dementia
Medical advances and better knowledge of health have contributed to increased life expectancy and a growing elderly ...
clinicaltrialsarena17h
Amgen speaks out about bone density concerns with obesity drug
The datapoint about BMD was discovered in a ‘hidden tab’ in Amgen’s data on Amgen’s Phase I trial MariTide data. Credits: Marlon Trottmann/Shutterstock.com Amgen has spoken out about concerns related ...